Antibody-drug Conjugate Information

General Information of This Antibody-drug Conjugate (ADC)

ADC ID	DRG0JGJDN
ADC Name	HBM9033
Synonyms	HBM 9033; HBM-9033; HBM9033; PF-08052666; PF 08052666; PF08052666; SGN-MesoC2 Click to Show/Hide
Organization	Harbour Biomed Therapeutics Ltd.
Drug Status	Phase 1
Indication	In total 7 Indication(s) Colorectal cancer Phase 1 Clinical Trial Endometrial cancer Phase 1 Clinical Trial Lung cancer Phase 1 Clinical Trial Melanoma Phase 1 Clinical Trial Ovarian cancer Phase 1 Clinical Trial Pancreatic cancer Phase 1 Clinical Trial Solid tumor Phase 1 Clinical Trial
Drug-to-Antibody Ratio	Undisclosed
	3D MOL	2D MOL
Antibody Name	Undisclosed
Antigen Name	Mesothelin (MSLN)		Antigen Info
Payload Name	Undisclosed
Linker Name	Undisclosed
Conjugate Type	Undisclosed